ExoticRx · exoticrx.com/drugs/tiludronate
Tildren
Bisphosphonate that inhibits osteoclast-mediated bone resorption by binding to hydroxyapatite in bone. Does not impair bone mineralization.
FDA-approved for navicular disease in horses. IV infusion over 90 minutes. Transient colic, renal toxicity at high doses. Do not use in horses with renal disease.
Species references:All Dog (Domestic) drugs
Each ExoticRx dose rule is graded by the strength of its primary evidence — see the editorial process.
A dog/cat sample is shown here. Cited dosing for all 1 species — reptiles, birds, pocket pets, livestock, and equine — is free on the per-species pages above. Pro adds the weight-based calculator for every species.
| Species | Route | Dose | Frequency | Evidence | Source |
|---|---|---|---|---|---|
| Dog (Domestic) | IV | 0.1–0.3 mg/kg | IV infusion q28 days | Weak | Plumb's Veterinary Drug Handbook, 9th Ed |
Upgrade to Pro or Student to unlock the full dose ranges and frequency for every species. The drug's mechanism, warnings, indications, and cited sources are free to read.
View PlansSource citations and evidence levels available on the live page. Reference only — verify against current literature before clinical use.